CHRISTIAN HIESSE, M.D.; B. CHARPENTIER, M.D.; D. FRIES, M.D.; G SIMONNEAU, M.D.; J. F. DELFRAISSY, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Recent reports have focused attention on recipients of kidney allografts or transfusions from donors infected with the human immunodeficiency virus (HIV; formerly known as HTLV-III/LAV) (1-4). The question remains as to whether immunosuppressive therapy in such patients alters the course of HIV infection and enhances the development of full-blown acquired immunodeficiency syndrome (AIDS).
Since January 1984, 250 patients who received kidney transplants in our institution have been screened for anti-HIV antibodies by radioimmunoprecipitation assay (cysteine) at 6 months after transplantation. Since August 1985, all recipients (tested 1 day before transplantation), kidney donors, and blood-products donors have been
HIESSE C, CHARPENTIER B, FRIES D, et al. Human Immunodeficiency Virus Infection in Transplant Recipients. Ann Intern Med. 1986;105:301. doi: 10.7326/0003-4819-105-2-301_1
Download citation file:
© 2019
Published: Ann Intern Med. 1986;105(2):301.
DOI: 10.7326/0003-4819-105-2-301_1